Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

48.17
-1.1800-2.39%
Post-market: 48.200.0300+0.06%19:56 EDT
Volume:5.85M
Turnover:284.22M
Market Cap:97.43B
PE:15.40
High:49.05
Open:48.93
Low:48.17
Close:49.35
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.87
T/O Rate:0.30%
Dividend:1.80
Dividend Rate:3.74%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.17
PE(LYR):12.89

Loading ...

GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients

TIPRANKS
·
Jul 13

J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 13

Guggenheim Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 10

GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China

TIPRANKS
·
Jul 10

Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen

Deep News
·
Jul 10

GSK price target raised to 1,950 GBp from 1,900 GBp at Deutsche Bank

TIPRANKS
·
Jul 10

GSK US President Acquires Notional ADS Under Executive Savings Plan

TIPRANKS
·
Jul 09

GSK Adds Philips CEO Roy Jakobs to Board as Independent Director

TIPRANKS
·
Jul 09

SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE

Deep News
·
Jul 09

Alector Ends GSK Collaboration, Retires Hercules Capital Debt

TIPRANKS
·
Jul 09

GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio

TIPRANKS
·
Jul 09

GSK Targets Pediatric Vaccine Growth With New Phase 3 Trial Against Merck’s ProQuad

TIPRANKS
·
Jul 09

GSK Advances Novel Malaria Drug Into Phase 2A, Signaling Long-Term Global Health Upside

TIPRANKS
·
Jul 09

GSK Advances New Malaria Drug With Completed First-in-Human Study

TIPRANKS
·
Jul 09

Dow Jones Top Company Headlines at 7 am ET: Apple to Spend $30 Billion on U.s.-made Chips from Broadcom | Trump-backed ...

Dow Jones
·
Jul 08

GSK, Sino Biopharmaceutical Unit Expand Collaboration to Cover Two GSK Respiratory Therapies

MT Newswires Live
·
Jul 08

Barclays Remains a Sell on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 08

Dow Jones Top Company Headlines at 3 am ET: Sino Biopharm Strikes Drug Licensing Deal with Astrazeneca, Deepens GSK Partnership | White ...

Dow Jones
·
Jul 08

Sino Biopharm Deepens GSK Respiratory Deal to Cement China Lead

TIPRANKS
·
Jul 08

GSK’s StrateGIST Frontline Trial Puts New Cancer Drug Velzatinib in the Spotlight

TIPRANKS
·
Jul 08